{
  "drug_name": "Icatibant",
  "url": "https://wikem.org/wiki/Icatibant",
  "scraped_at": "2026-01-10T07:55:18.200615",
  "sections": {
    "General": {
      "text": "Type: Bradykinin receptor antagonist\nDosage Forms: 30mg\nRoutes of Administration: Subcutaneous\nCommon Trade Names: Firazyr",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Adult_Dosing": {
      "text": "",
      "subsections": {
        "Hereditary_angioedema": {
          "text": "30mg subcutaneous x 1\nMay repeat q6h if inadequate response/symptoms recur\nMax 90mg/24 hours",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Hereditary_angioedema": {
      "text": "30mg subcutaneous x 1\nMay repeat q6h if inadequate response/symptoms recur\nMax 90mg/24 hours",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pediatric_Dosing": {
      "text": "not available (8/2015)",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Special_Populations": {
      "text": "Pregnancy Rating\n: C\nLactation risk\n: safety unknown\nRenal Dosing\nHepatic Dosing",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Pregnancy Rating",
          "url": "https://wikem.org/wiki/Drug_Ratings_in_Pregnancy"
        },
        {
          "text": "Lactation risk",
          "url": "https://wikem.org/wiki/Lactation_risk_categories"
        }
      ]
    },
    "Contraindications": {
      "text": "Allergy to class/drug",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Adverse_Reactions": {
      "text": "",
      "subsections": {
        "Serious": {
          "text": "Caution if acute MI\nCaution if unstable angina\nCaution if recent stroke",
          "tables": []
        },
        "Common": {
          "text": "Injection site reaction\nDizziness\nFever\nIncreased LFTs",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Serious": {
      "text": "Caution if acute MI\nCaution if unstable angina\nCaution if recent stroke",
      "subsections": {
        "Common": {
          "text": "Injection site reaction\nDizziness\nFever\nIncreased LFTs",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Common": {
      "text": "Injection site reaction\nDizziness\nFever\nIncreased LFTs",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pharmacology": {
      "text": "Half-life: 1.4h\nMetabolism: Proteolytic degradation\nExcretion: Urine 10% unchanged\nMechanism of Action: selectively antagonizes bradykinin B2 receptor",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Comments": {
      "text": "NEJM article 1/2015 randomized 27 people with ACEi induced angioedema to icatibant vs std therapy (Prednisone 500mg + Clemastine 2mg) looking at time to resolution.\nRESULTS- significantly shorter (8 hrs vs 27.1 hrs) in icatibant group.\nCost according to Goodrx= $9,000/dose (on 8/7/2015)",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "See_Also": {
      "text": "Angioedema (Upper Airway)",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Angioedema (Upper Airway)",
          "url": "https://wikem.org/wiki/Angioedema_(Upper_Airway)"
        }
      ]
    }
  }
}